Media & PR
Groundbreaking Case Report on World’s First 35mm myVal TAVI Implant for Aortic Regurgitation Featured in Catheterization and Cardiovascular Interventions
Team myHart is proud to announce the publication of its pivotal case report in Catheterization and Cardiovascular Interventions (CCI), widely recognized as the most prestigious journal in the field of interventional cardiology.
The report details the world’s first successful implantation of the 35mm myVal transcatheter aortic valve for the treatment of aortic regurgitation.
This publication underscores a major milestone in cardiovascular medicine, demonstrating the expanded utility of TAVI technology and potentially opening new avenues for patients with severe aortic regurgitation who may not be candidates for traditional surgical interventions.
Thanks for your continued support and encouragement.
The report details the world’s first successful implantation of the 35mm myVal transcatheter aortic valve for the treatment of aortic regurgitation.
This publication underscores a major milestone in cardiovascular medicine, demonstrating the expanded utility of TAVI technology and potentially opening new avenues for patients with severe aortic regurgitation who may not be candidates for traditional surgical interventions.
Thanks for your continued support and encouragement.
